As-needed budesonide-formoterol better controlled mild asthma vs terbutaline, but maintenance budesonide was better

被引:0
|
作者
Stanbrook, Matthew B. [1 ]
机构
[1] Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada
关键词
D O I
10.7326/ACPJC-2018-169-6-031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:JC31 / JC31
页数:1
相关论文
共 50 条
  • [31] A Pilot Randomized Trial of As-Needed Budesonide-Formoterol for Stepping Down Controller Treatment in Moderate Asthma with Complete Remission
    Nakwan, Narongwit
    Ruklerd, Thidarat
    Taptawee, Pattarawadee
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2022, 85 (03) : 227 - 236
  • [32] Cost-effectiveness of budesonide-formoterol vs inhaled epinephrine in US adults with mild asthma
    Ho, Joseph Khoa
    Shaker, Marcus
    Greenhawt, Matthew
    Sadatsafavi, Mohsen
    Abrams, Elissa M.
    Oppenheimer, John
    Mosnaim, Giselle S.
    Lee, Tae Yoon
    Johnson, Kate M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (02) : 229 - 239.e3
  • [33] Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma
    Papi, Alberto
    Braithwaite, Irene
    Ebmeier, Stefan
    Hancox, Robert J.
    Harrison, Tim
    Holliday, Mark
    Houghton, Claire
    Morandi, Luca
    Oldfield, Karen
    Pavord, Ian D.
    Reddel, Helen K.
    Williams, Mathew
    Weatherall, Mark
    Beasley, Richard
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (02)
  • [34] Efficacy of budesonide/formoterol maintenance and reliever therapy in mild asthma
    Jenkins, Christine
    Eriksson, Goeran
    Bateman, Eric D.
    Reddel, Helen K.
    Sears, Malcolm R.
    Fageras, Malin
    Lindberg, Magnus B.
    O'Byrne, Paul M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [35] Is It Really Feasible to Use Budesonide-Formoterol as Needed for Mild Persistent Asthma? A Systematic Review and Meta-Analysis
    Tong, Xiang
    Liu, Tao
    Li, Zhenzhen
    Liu, Sitong
    Fan, Hong
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [36] Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective
    FitzGerald, J. Mark
    Arnetorp, Sofie
    Smare, Caitlin
    Gibson, Danny
    Coulton, Karen
    Hounsell, Kirsty
    Sadatsafavi, Mohsen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [37] As-needed ICS/formoterol or as-needed SABA in mild asthma?
    Krishnan, Jerry A.
    Buhl, Roland
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2024, 63 (04)
  • [38] Influence of Prior Treatment Upon the Efficacy of As-Needed Budesonide/Formoterol in Mild Asthma in the SYGMA 1 and 2 Studies
    Bateman, E.
    O'Byrne, P. M.
    FitzGerald, J. M.
    Barnes, P. J.
    Zhong, N.
    Alagappan, V.
    Whelan, G.
    Lamarca, R.
    Puu, M.
    Reddel, H. K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [39] Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial
    Hardy, Jo
    Baggott, Christina
    Fingleton, James
    Reddel, Helen K.
    Hancox, Robert J.
    Harwood, Matire
    Corin, Andrew
    Sparks, Jenny
    Hall, Daniela
    Sabbagh, Donah
    Mane, Saras
    Vohlidkova, Alexandra
    Martindale, John
    Williams, Mathew
    Shirtcliffe, Philippa
    Holliday, Mark
    Weatherall, Mark
    Beasley, Richard
    [J]. LANCET, 2019, 394 (10202): : 919 - 928
  • [40] Asthma control in Greek patients receiving FDC of Budesonide/Formoterol as maintenance and/or as-needed treatment. The NOTOS study
    Rovina, Nikoletta
    Samitas, Konstantinos
    Krommidas, Georgios
    Latsios, Dimitrios
    Bertoli, Maria
    Ginis, Alexandros
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62